Full-Time

Senior Calibration Technician

Updated on 9/4/2026

Deadline 8/12/27
Transcat

Transcat

1,001-5,000 employees

Calibration services and test equipment distributor

Compensation Overview

$41 - $47/hr

+ $3,000 sign-on bonus

Fullerton, CA, USA

In Person

Travel may be required for up to 50% of the work schedule.

Associate's

Category
Manufacturing Quality & Test
Required Skills
Microsoft Office
Metrology
Word/Pages/Docs
Customer Service
Data Analysis
Excel/Numbers/Sheets
Microsoft Outlook

Get referred to Transcat

See people who can refer or advise you

Requirements
  • Successful completion of assigned training materials through on-the-job training, online content, the learning management system, and classroom-led instruction.
  • Proficiency with electrical calibrations.
  • At least three years of driving experience, a valid driver's license, and an acceptable driving history.
  • An Associate degree from a college or technical school, or six or more years of related experience and/or training, or an equivalent combination of education and experience.
  • Ability to perform calibration, troubleshooting, and adjustment of high-level equipment across calibration disciplines.
  • Ability to work independently with little to no supervision in a laboratory or customer onsite setting.
  • Ability to identify and apply appropriate measurement techniques and measurement uncertainties.
  • Ability to read and interpret laboratory scopes of accreditation.
  • Ability to coordinate daily workloads and work schedules.
  • Ability to conduct independent research and prepare detailed analyses of calibration processes and uncertainties.
  • Ability to develop and implement process improvements.
  • Ability to work safely around electrical, mechanical, chemical, weather, height, vibration, and other workplace hazards.
  • Ability to occasionally lift up to 75 pounds.
Responsibilities
  • Perform calibration work with little to no supervision.
  • Conduct independent research when necessary.
  • Coordinate and manage daily workloads without direction from the service manager.
  • Identify and utilize appropriate measurement techniques.
  • Maintain calibration standards.
  • Understand and apply uncertainties to measurements made.
  • Read and interpret laboratory scopes of accreditation.
  • Work effectively with laboratory support staff.
  • Perform calibrations within a laboratory or at customer onsite locations.
  • Work at customer onsite locations with little to no direction.
  • Fulfill duties safely under working conditions in keeping with company requirements and standards.
  • Calibrate, troubleshoot, and adjust a high volume of high-level equipment with few errors.
  • Coordinate the laboratory work schedule.
  • Prepare detailed analyses of calibration processes and uncertainties.
  • Develop and implement process improvements.
  • Develop team-lead skills and responsibilities.
  • Train and advise lower-level technicians.
  • Deliver on Transcat’s Quality Policy (QAC-F01-001).
Desired Qualifications
  • At least six years of commercial calibration experience.
  • RF calibration experience.
  • Working knowledge and competency in eight calibration disciplines and expertise in three disciplines.
  • CCT or CMT certification.
  • An extensive statistical background.
  • Advanced proficiency with Microsoft Office, including Word, Excel, and Outlook.
  • Advanced organizational and time-management skills.
  • Experience in PMEL, PME, TMDE, metrology, calibration, ASQ CCT, METCAL, GPETE, electronics, GCAMS, or avionics.

Transcat provides calibration services and distributes test and measurement equipment across North America. It began as a tool manufacturer, then became a distributor, and later focused on high-value services by opening calibration labs to ensure instruments meet precise standards. Their products and services work by calibrating instruments in trusted labs to national or industry standards, offering traceable, documented calibration results and related support. The company differentiates itself through a nationwide service network and growth via strategic acquisitions, expanding its geographic reach and technical capabilities in tightly regulated sectors such as life sciences, aerospace, and energy. Its goal is to help customers maintain accurate, compliant measurement tools and equipment, enabling reliable operations in highly regulated industries.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Town of Ogden, New York

Founded

1964

Get referred to Transcat

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 26, 2026 revenue hit $331.9 million, up 19.2% for fiscal 2026.
  • Service revenue grew 7% organically in Q4, extending 68 consecutive quarters of growth.
  • August 31, 2026 Southeastern Biomedical expands biomedical reach across the Southeast immediately.

What critics are saying

  • May 2026 operating expenses jumped 37.8%, crushing operating margin despite revenue growth.
  • August 31, 2026 Southeastern Biomedical adds integration risk, holdback disputes, and customer churn.
  • Strategic M&A dependence creates existential execution risk if financing or targets dry up.

What makes Transcat unique

  • Transcat’s 30-plus accredited labs create sticky national coverage for regulated customers.
  • Its service mix targets life sciences, aerospace, energy, and hospital compliance workflows.
  • Acquisitions like SCM Metrology and Southeastern Biomedical extend geography faster than greenfield expansion.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Tuition Reimbursement

Employee Stock Purchase Plan

Paid Vacation

Flexible Work Hours

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
BridgeTower Media
Sep 1st, 2026
Transcat expands biomedical business with $12.8M acquisition.

Transcat expands biomedical business with $12.8M acquisition. Rochester-based Transcat Inc. is expanding its biomedical calibration business into the southeastern U.S. with the $12.8 million acquisition of a North Carolina company that serves hospitals and health care facilities. Transcat announced this week that it acquired privately held Southeastern Biomedical Associates Inc. The purchase price was paid in cash and is subject to customary adjustments and holdback provisions. Founded in 1996 and based in Granite Falls, North Carolina, Southeastern provides calibration, repair, preventive maintenance, electrical safety inspections, documentation and regulatory compliance services to hospital networks and other health care facilities throughout the Southeast and beyond. The company also sells biomedical equipment, patient-ready accessories and equipment parts. Its services include helping customers acquire equipment and liquidate assets. The acquisition builds on Transcat's existing biomedical business while expanding its geographic reach in a market the company expects to grow, according to company leaders. For Transcat, the deal is part of a broader strategy to build scale in highly regulated industries where equipment failures can carry significant financial, operational and safety consequences. "The acquisition of Southeastern Biomedical reinforces Transcat's strategy of deepening our presence in the Life Science sector, one of the most regulated and mission-critical end markets we serve," said Jaime Irick, Transcat's president and CEO. Transcat has more than 30 calibration laboratories across North and Central America. The company sees that footprint as a competitive advantage as hospital networks and other regulated customers increasingly need consistent, accredited calibration services across multiple locations. Irick said Southeastern's reputation and customer base will allow Transcat to serve a larger geography while maintaining its focus on quality and turnaround times. The acquisition also brings Southeastern's employees and owners into Transcat. Co-owners Boyd Campbell and Greg Johnson will join the company. Southeastern has built its business over more than three decades serving customers throughout the Southeast and beyond, Johnson said. He said Transcat was the right partner to support the company's next phase of growth. "Transcat has developed a reputation in this industry for treating acquired employees and customers right," Johnson said, adding that he and Campbell look forward to being part of the future of Transcat Biomedical. The acquisition comes as Transcat continues to emphasize mergers and acquisitions as part of its growth strategy. Irick said the combination should create opportunities to expand service across the companies' customer bases while maintaining what he described as industry-leading turnaround times.

MEDQOR
Aug 31st, 2026
Transcat acquires Southeastern Biomedical.

Transcat acquires Southeastern Biomedical. The acquisition expands Transcat's biomedical service footprint across the Southeast, including calibration, repair, and preventive maintenance for healthcare facilities. Transcat has acquired Southeastern Biomedical Associates for $12.8 million in cash, effective Aug 31, 2026. The acquisition expands Transcat's accredited biomedical calibration, equipment repair, and preventive maintenance services throughout the southeastern United States. Based in Granite Falls, NC, Southeastern Biomedical Associates provides calibration, repair, electrical safety inspection, and regulatory compliance services to hospital networks and healthcare facilities. The company's services conform to both ISO/IEC 17025 and ISO 9001 standards. In addition to service, the company sells biomedical equipment, patient-ready accessories, and equipment parts. The acquisition is intended to build scale in regulated end markets where accredited calibration is critical to patient safety and regulatory compliance, according to a release from Transcat. Transcat operates more than 30 calibration labs across North and Central America. "The acquisition of Southeastern Biomedical reinforces Transcat's strategy of deepening our presence in the Life Science sector, one of the most regulated and mission-critical end markets we serve," says Jaime Irick, president and CEO, in a release. "Southeastern's reputation for high quality and a customer-first approach supporting hospital networks throughout the southeastern region of the United States and beyond builds on our established leadership in biomedical calibration and will position us to service a much larger geography with a consistent focus on quality and timely service for our customers in these critical end markets." Southeastern Biomedical Associates owners Boyd Campbell and Greg Johnson will remain with Transcat to lead the growth of the combined biomedical business. "There was never a doubt that Transcat was the right partner to take our company to the next level of growth," says Greg Johnson, co-owner of Southeastern Biomedical Associates, in a release. "Transcat has developed a reputation in this industry for treating acquired employees and customers right, and for focusing on the key attributes and operating principles that have made Southeastern successful over time." The purchase price is subject to certain customary adjustments and holdback provisions. According to Transcat, the acquisition supports the company's fiscal 2027 outlook, which includes continued mergers and acquisitions and service gross margin expansion.

Yahoo Finance
Aug 13th, 2026
Transcat beats revenue estimates by 7.4% with 21.6% growth in calibration and distribution services

Transcat reported second-quarter results that beat Wall Street expectations, with revenue reaching $92.95 million against estimates of $86.55 million. The calibration and laboratory equipment company posted adjusted earnings per share of $0.51, surpassing analyst forecasts of $0.38. The company saw double-digit growth in both its Service and Distribution segments. CEO Jaime Irick attributed the performance to strong demand in regulated markets including life sciences, aerospace, and energy. During the earnings call, analysts focused on sustainability of growth drivers. Questions centred on end market performance, the company's rental business trajectory, and AI productivity improvements. Lake Street Capital asked about the rental business outlook, with CFO Thomas Barbato projecting high single-digit to low double-digit growth. Analysts also probed margin sustainability and market share potential. Operating margin declined to 5.5% from 7% year-on-year.

Yahoo Finance
Aug 5th, 2026
Transcat posts 27% service revenue growth, eyes high single-digit organic growth for FY2027

Transcat Inc reported strong fiscal Q1 2027 results, with consolidated revenue rising 22% to $92.9 million, driven by double-digit growth in both segments. Service revenue grew 27% year-over-year, including 13% organic growth — marking the 69th consecutive quarter of service revenue expansion. Service gross profit increased 31%, with margins expanding 90 basis points due to operational leverage and maturing customer relationships. The company's recent acquisition of SCM Metrology and Laboratories is progressing well, expanding its Central America presence. However, diluted earnings per share fell to $0.14, impacted by increased intangible asset amortisation, stock-based compensation, interest expense, and executive transition costs. Distribution segment gross margins decreased 380 basis points to 31.4% due to unusually high prior-year vendor rebates. Management expressed confidence in achieving high single-digit service organic growth for the full fiscal year, citing strong demand across life sciences, aerospace, and defence sectors.

Yahoo Finance
Aug 4th, 2026
Transcat reports Q2 revenue of $92.95M, up 21.6% year-on-year, beating estimates by 7.4%

Transcat reported second quarter 2026 results that exceeded revenue expectations, with sales reaching $92.95 million, up 21.6% year-on-year and 7.4% above analyst estimates of $86.55 million. The measurement equipment distributor posted non-GAAP earnings of $0.51 per share, beating consensus estimates of $0.38 by 35.1%. Adjusted EBITDA came in at $14 million, surpassing analyst expectations of $12.46 million by 12.4%, representing a 15.1% margin. Free cash flow improved to $4.84 million from negative $975,000 in the same quarter last year. However, operating margin declined to 4% from 7.1% in the prior-year quarter. Analysts forecast revenue growth of 6% over the next 12 months, a slowdown from the company's recent 14.5% two-year growth rate.